asa glp 1 agonist guidelines GLP-1 medications safe to continue before surgery in patients with diabetes and obesity How should we approach patients
Description
The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.
These findings align with prior randomized trials and meta-analyses suggesting class-level cardiovascular benefit
The term natural is often misunderstood
Those who took Ozempic or a similar drug had a 40% lower chance of overdosing on opioids and a 50% lower chance of getting drunk compared to those who didn't take the medication, the study found.
